Home/Filings/4/0001673232-26-000003
4//SEC Filing

BENKOWITZ MICHAEL 4

Accession 0001673232-26-000003

CIK 0001082554other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:30 PM ET

Size

38.4 KB

Accession

0001673232-26-000003

Insider Transaction Report

Form 4
Period: 2026-01-05
BENKOWITZ MICHAEL
PRESIDENT AND COO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-05$146.03/sh+7,875$1,149,9867,875 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$480.68/sh376$180,7377,499 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$481.86/sh891$429,3396,608 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$482.72/sh471$227,3606,137 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$483.80/sh375$181,4275,762 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$484.99/sh629$305,0615,133 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$486.05/sh899$436,9594,234 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$487.40/sh461$224,6933,773 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$488.38/sh641$313,0493,132 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$489.49/sh364$178,1742,768 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$490.11/sh893$437,6691,875 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$491.35/sh647$317,9031,228 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$492.44/sh598$294,482630 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$493.47/sh201$99,188429 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$494.27/sh429$212,0430 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Options

    2026-01-057,87552,315 total(indirect: By Trust)
    Exercise: $146.03From: 2020-03-15Exp: 2027-03-15Common Stock (7,875 underlying)
Holdings
  • Common Stock

    2,648
Footnotes (16)
  • [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.
  • [F10]This transaction was executed in multiple trades at prices ranging from $488.90 to $489.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F11]This transaction was executed in multiple trades at prices ranging from $489.90 to $490.885. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F12]This transaction was executed in multiple trades at prices ranging from $490.90 to $491.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F13]This transaction was executed in multiple trades at prices ranging from $491.91 to $492.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F14]This transaction was executed in multiple trades at prices ranging from $492.96 to $493.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F15]This transaction was executed in multiple trades at prices ranging from $493.99 to $494.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F16]Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
  • [F2]This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $481.32 to $482.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $482.34 to $483.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $483.47 to $484.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $484.54 to $485.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $485.58 to $486.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]This transaction was executed in multiple trades at prices ranging from $486.79 to $487.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F9]This transaction was executed in multiple trades at prices ranging from $487.90 to $488.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

UNITED THERAPEUTICS Corp

CIK 0001082554

Entity typeother

Related Parties

1
  • filerCIK 0001673232

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:30 PM ET
Size
38.4 KB